$4.04
-0.03-0.74%
Pre-Market: 4:23 PM EDT
15 minutes delayed
Comments
Loading...
Outset Medical
OMNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Outset Medical (NASDAQ:OM) Stock, Analyst Ratings, Price Targets, Forecasts
Outset Medical Inc has a consensus price target of $24.65 based on the ratings of 11 analysts. The high is $55 issued by SVB Leerink on May 5, 2022. The low is $3 issued by B of A Securities on October 13, 2023. The 3 most-recent analyst ratings were released by RBC Capital, BTIG, and RBC Capital on June 21, 2024, April 8, 2024, and January 12, 2024, respectively. With an average price target of $6 between RBC Capital, BTIG, and RBC Capital, there's an implied 48.51% upside for Outset Medical Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
RBC Capital
BTIG
Morgan Stanley
Stifel
B of A Securities
1calculated from analyst ratings
Analyst Ratings for Outset Medical
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/21/2024 | Buy Now | 48.51% | RBC Capital | Shagun Singh | $5 → $6 | Upgrade | Sector Perform → Outperform | Get Alert |
| 04/08/2024 | Buy Now | 48.51% | BTIG | Maria Thibault | → $6 | Initiates | → Buy | Get Alert |
| 01/12/2024 | Buy Now | 48.51% | RBC Capital | Shagun Singh | $14 → $6 | Downgrade | Outperform → Sector Perform | Get Alert |
| 12/04/2023 | Buy Now | 36.14% | Morgan Stanley | Drew Ranieri | $5 → $5.5 | Maintains | Equal-Weight | Get Alert |
| 11/14/2023 | Buy Now | 23.76% | Morgan Stanley | Drew Ranieri | $19 → $5 | Maintains | Equal-Weight | Get Alert |
| 10/13/2023 | Buy Now | 320.79% | RBC Capital | Shagun Singh | $29 → $17 | Maintains | Outperform | Get Alert |
| 10/13/2023 | Buy Now | 48.51% | Stifel | Rick Wise | $26 → $6 | Maintains | Buy | Get Alert |
| 10/13/2023 | Buy Now | -25.74% | B of A Securities | Travis Steed | $32 → $3 | Downgrade | Buy → Underperform | Get Alert |
| 08/24/2023 | Buy Now | 370.3% | Morgan Stanley | Drew Ranieri | $22 → $19 | Maintains | Equal-Weight | Get Alert |
| 08/17/2023 | Buy Now | 617.82% | RBC Capital | Shagun Singh | → $29 | Reiterates | Outperform → Outperform | Get Alert |
| 08/17/2023 | Buy Now | — | CL King | Kristen Stewart | — | Initiates | → Neutral | Get Alert |
| 08/03/2023 | Buy Now | 444.55% | Morgan Stanley | Drew Ranieri | $23 → $22 | Maintains | Equal-Weight | Get Alert |
| 05/31/2023 | Buy Now | 469.31% | Morgan Stanley | Drew Ranieri | $27 → $23 | Maintains | Equal-Weight | Get Alert |
| 05/15/2023 | Buy Now | 617.82% | RBC Capital | Shagun Singh | → $29 | Reiterates | Outperform → Outperform | Get Alert |
| 05/04/2023 | Buy Now | 617.82% | RBC Capital | Shagun Singh | $32 → $29 | Maintains | Outperform | Get Alert |
| 01/06/2023 | Buy Now | 568.32% | Morgan Stanley | Drew Ranieri | $17 → $27 | Maintains | Equal-Weight | Get Alert |
| 11/11/2022 | Buy Now | 469.31% | RBC Capital | Shagun Singh | → $23 | Initiates | → Outperform | Get Alert |
| 11/10/2022 | Buy Now | 320.79% | Morgan Stanley | Drew Ranieri | $19 → $17 | Maintains | Equal-Weight | Get Alert |
| 11/09/2022 | Buy Now | 617.82% | Goldman Sachs | Amit Hazan | $34 → $29 | Maintains | Buy | Get Alert |
| 10/11/2022 | Buy Now | 370.3% | Morgan Stanley | Drew Ranieri | $22 → $19 | Maintains | Equal-Weight | Get Alert |
| 08/03/2022 | Buy Now | 741.58% | Goldman Sachs | Amit Hazan | $48 → $34 | Maintains | Buy | Get Alert |
| 08/02/2022 | Buy Now | 444.55% | Morgan Stanley | Drew Ranieri | $20 → $22 | Maintains | Equal-Weight | Get Alert |
| 07/18/2022 | Buy Now | 494.06% | Stifel | Rick Wise | $30 → $24 | Maintains | Buy | Get Alert |
| 07/14/2022 | Buy Now | 395.05% | Morgan Stanley | Drew Ranieri | $48 → $20 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 06/14/2022 | Buy Now | 716.83% | Cowen & Co. | Joshua Jennings | $60 → $33 | Maintains | Outperform | Get Alert |
| 06/14/2022 | Buy Now | 642.57% | Stifel | Rick Wise | $55 → $30 | Maintains | Buy | Get Alert |
| 05/05/2022 | Buy Now | 1088.12% | Morgan Stanley | David Lewis | $50 → $48 | Maintains | Overweight | Get Alert |
| 05/05/2022 | Buy Now | 1261.39% | SVB Leerink | Danielle Antalffy | $65 → $55 | Maintains | Outperform | Get Alert |
| 08/18/2021 | Buy Now | 1632.67% | Cowen & Co. | Joshua Jennings | — | Initiates | → Outperform | Get Alert |
| 08/09/2021 | Buy Now | 1261.39% | Morgan Stanley | — | — | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Outset Medical (OM) stock?
The latest price target for Outset Medical (NASDAQ:OM) was reported by RBC Capital on June 21, 2024. The analyst firm set a price target for $6.00 expecting OM to rise to within 12 months (a possible 48.51% upside). 12 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Outset Medical (OM)?
The latest analyst rating for Outset Medical (NASDAQ:OM) was provided by RBC Capital, and Outset Medical upgraded their outperform rating.
When was the last upgrade for Outset Medical (OM)?
The last upgrade for Outset Medical Inc happened on June 21, 2024 when RBC Capital raised their price target to $6. RBC Capital previously had a sector perform for Outset Medical Inc.
When was the last downgrade for Outset Medical (OM)?
The last downgrade for Outset Medical Inc happened on January 12, 2024 when RBC Capital changed their price target from $14 to $6 for Outset Medical Inc.
When is the next analyst rating going to be posted or updated for Outset Medical (OM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Outset Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Outset Medical was filed on June 21, 2024 so you should expect the next rating to be made available sometime around June 21, 2025.
Is the Analyst Rating Outset Medical (OM) correct?
While ratings are subjective and will change, the latest Outset Medical (OM) rating was a upgraded with a price target of $5.00 to $6.00. The current price Outset Medical (OM) is trading at is $4.04, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.